Skip to content

H.R. 5957 · 118th Congress (2023–2025)

Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023

This bill requires the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in menstrual products and intimate care products pose health risks to people who use the products or to the children of people who use the products during or before pregnancy.

Show official title

To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 5957’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Grace Meng (D-NY-6)
Cosponsors
14 cosponsors

6 original · 8 later

14 D

  1. Rep. Judy Chu (D-CA-28)· Original · Oct 13, 2023
  2. Rep. Jasmine Crockett (D-TX-30)· Original · Oct 13, 2023
  3. Rep. Ro Khanna (D-CA-17)· Original · Oct 13, 2023
  4. Rep. Gwen Moore (D-WI-4)· Original · Oct 13, 2023
  5. Rep. Janice D. Schakowsky (D-IL-9)· Original · Oct 13, 2023
  6. Rep. Bonnie Watson Coleman (D-NJ-12)· Original · Oct 13, 2023
  7. Rep. Alma S. Adams (D-NC-12)· Later · Oct 17, 2023
  8. Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Oct 17, 2023
  9. Rep. Nanette Diaz Barragán (D-CA-44)· Later · Oct 30, 2023
  10. Rep. Yvette D. Clarke (D-NY-9)· Later · Oct 30, 2023
  11. Rep. Nydia M. Velázquez (D-NY-7)· Later · Oct 30, 2023
  12. Rep. Steve Cohen (D-TN-9)· Later · Feb 6, 2024
  13. Rep. Marie Gluesenkamp Perez (D-WA-3)· Later · Feb 28, 2024
  14. Rep. Rashida Tlaib (D-MI-12)· Later · Jun 25, 2024
Policy area
Health
Subjects
  • Child health
  • Hazardous wastes and toxic substances
  • Medical research
  • Research administration and funding
  • Sex and reproductive health
  • Women's health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Oct 25, 2023 – Nov 3, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Oct 25, 2023
  2. HouseHealthReferred Nov 3, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023

    Display title, Short title · Introduced in House

  2. To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products.

    Official title · Introduced in House